Treatment for hypertension, male in Europe & Central Asia
Europe & Central Asia: Treatment for hypertension, male was 47.7% in 2019. ▲ Rising
Treatment for hypertension, male in Europe & Central Asia, 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of male adults ages 30-79 with hypertension.
Analysis
Europe & Central Asia recorded 47.7% for treatment for hypertension, male in 2019. That is the highest value across all 30 years on record.
The figure is up 1.4% on the previous year and up 20.4% over ten years.
Over the whole period, treatment for hypertension, male in Europe & Central Asia peaked at 47.7% in 2019 and was at its lowest, 19.1%, in 1990.
That places Europe & Central Asia 8th out of 43 groups with data for 2019, putting it in the top quarter.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, male in Europe & Central Asia, year by year
| Year | % of male adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 19.1% | — |
| 1991 | 19.9% | +4.2% |
| 1992 | 20.8% | +4.2% |
| 1993 | 21.7% | +4.3% |
| 1994 | 22.6% | +4.3% |
| 1995 | 23.6% | +4.4% |
| 1996 | 24.7% | +4.4% |
| 1997 | 25.7% | +4.3% |
| 1998 | 26.8% | +4.1% |
| 1999 | 27.9% | +4.2% |
| 2000 | 29.1% | +4.1% |
| 2001 | 30.2% | +4.0% |
| 2002 | 31.5% | +4.0% |
| 2003 | 32.7% | +3.9% |
| 2004 | 33.9% | +3.8% |
| 2005 | 35.1% | +3.6% |
| 2006 | 36.3% | +3.4% |
| 2007 | 37.5% | +3.1% |
| 2008 | 38.6% | +2.9% |
| 2009 | 39.6% | +2.7% |
| 2010 | 40.6% | +2.6% |
| 2011 | 41.6% | +2.4% |
| 2012 | 42.6% | +2.3% |
| 2013 | 43.4% | +2.0% |
| 2014 | 44.2% | +1.8% |
| 2015 | 45.0% | +1.7% |
| 2016 | 45.7% | +1.6% |
| 2017 | 46.4% | +1.5% |
| 2018 | 47.1% | +1.4% |
| 2019 | 47.7% | +1.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 23.3% | 19.1% | 27.9% | 10 |
| 2000s | 34.4% | 29.1% | 39.6% | 10 |
| 2010s | 44.4% | 40.6% | 47.7% | 10 |
Countries ranked near Europe & Central Asia
More health data for Europe & Central Asia
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-64, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, annual growth rate 0.9265 % change on previous year (2025)
- Population ages 40-44, male, per capita 0.0351 units per person (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, annual growth rate -1.6 % change on previous year (2025)
- Population ages 40-44, male, annual growth rate 0.3995 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per capita 0.0355 units per person (2025)
Frequently asked questions
- What is treatment for hypertension, male in Europe & Central Asia?
- Treatment for hypertension, male in Europe & Central Asia was 47.7% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, male recorded in Europe & Central Asia?
- The highest recorded value was 47.7% in 2019.
- What is the lowest treatment for hypertension, male recorded in Europe & Central Asia?
- The lowest recorded value was 19.1% in 1990.
- How does Europe & Central Asia rank for treatment for hypertension, male?
- Europe & Central Asia ranks 8th out of 43 groups with data for 2019.
- Is treatment for hypertension, male rising or falling in Europe & Central Asia?
- Over the last ten years it is up 20.4%. The long-run trend across the full record is rising.
- Where does this Europe & Central Asia data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.